DXC Technology (DXC) Tops Q1 EPS by 9c

DXC Technology (NYSE: DXC) reported Q1 EPS of $0.21, $0.09 better than the analyst estimate of $0.12. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.32 billion.

"I was very pleased with our first quarter results as we exceeded our revenue and EPS targets along with delivering a strong book-to-bill of 1.2x. This is clear evidence that we are executing on our transformation journey,” said Mike Salvino, president and chief executive officer of DXC. “Our focus on customers is allowing us to stabilize revenues, expand margins, and bring the “new DXC” to the market, helping us win more work. We are also making solid progress on our strategic alternatives. We remain on-track to complete the sale of the US State and Local Health and Human Services business in the second quarter. The recent announcement of the sale of our healthcare software business will further enhance our financial flexibility. Finally, I am very proud of how our people have been delivering for our customers during COVID-19.”

Salvino added that the company expects to build on the current momentum in the second quarter by stabilizing revenues, improving margins and targeting a book-to-bill of 1x.

For earnings history and earnings-related data on DXC Technology (DXC) click here.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
• Teradyne (TER) Tops Q1 EPS by 18c